ASCO recently announced the upcoming launch of JCO Oncology Advances (JCO OA), a new open-access and interdisciplinary journal. Pamela Kunz, MD, will serve as the new Editor-in-Chief of this innovative journal, dedicated to accelerating progress in the global fight against cancer by providing a platform where innovation in cancer research meets accessibility.
Pamela Kunz, MD
Lynn Schuchter, MD, FASCO
“We are thrilled to welcome Dr. Kunz to lead JCO Oncology Advances,” said ASCO President Lynn Schuchter, MD, FASCO. “Her extensive expertise in medical oncology and vision for integrating scientific research with clinical care align perfectly with the mission of JCO OA. This new journal is a testament to ASCO’s commitment to advancing cancer care.”
Dr. Kunz, leading the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center, brings much experience to this role. She is also Division Chief of GI Medical Oncology at Yale and serves as Associate Professor of Internal Medicine, specializing in Medical Oncology, at the Yale School of Medicine. Her academic and professional journey, from the Geisel School of Medicine at Dartmouth to her leadership roles at Yale, makes her an ideal choice to spearhead this initiative.
Under Dr. Kunz’s leadership, JCO OA is committed to fostering interdisciplinary collaboration and making cutting-edge oncologic insights freely accessible, supporting the global effort to improve patient outcomes.
“Leading as the first Editor-in-Chief of JCO Oncology Advances, I am committed to shaping this platform into the foremost oncology open-access journal. By publishing a wide array of content, we aim to engage a diverse audience, encompassing academics, community practitioners, international colleagues, and patient partners,” said Dr. Kunz. “Our accessible online format empowers us to be innovative, agile, and impactful, extending our reach far beyond conventional boundaries.” The journal will open for submissions in the spring of 2024.
© 2024. American Society of Clinical Oncology. All rights reserved.
